PriceTargets.com logo

DraftKings - DKNG Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $54.75
  • Forecasted Upside: 62.03%
  • Number of Analysts: 29
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 26 Buy Ratings
  • 0 Strong Buy Ratings
$33.79 As of 04/25/2025 05:00 PM ET
▼ -0.39 (-1.14%)

This chart shows the closing price for DKNG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DraftKings Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DKNG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DKNG

Analyst Price Target is $54.75
▲ +62.03% Upside Potential
This price target is based on 29 analysts offering 12 month price targets for DraftKings in the last 3 months. The average price target is $54.75, with a high forecast of $65.00 and a low forecast of $35.00. The average price target represents a 62.03% upside from the last price of $33.79.

This chart shows the closing price for DKNG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 29 polled investment analysts is to moderate buy stock in DraftKings. This rating has held steady since August 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 22 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
11/2/2023
  • 0 strong buy ratings
  • 22 buy ratings
  • 2 hold ratings
  • 4 sell ratings
Ratings as of
1/31/2024
  • 0 strong buy ratings
  • 25 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
4/30/2024
  • 0 strong buy ratings
  • 26 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
7/29/2024
  • 0 strong buy ratings
  • 24 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2024
  • 0 strong buy ratings
  • 23 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2025
  • 0 strong buy ratings
  • 25 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2025
  • 0 strong buy ratings
  • 26 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2025

Latest Recommendations

  • 0 strong buy ratings
  • 26 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/25/2025CitigroupLower TargetBuy ➝ Buy$65.00 ➝ $55.00
4/24/2025BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$65.00
4/24/2025CowenReiterated RatingBuy ➝ Buy
4/24/2025TD SecuritiesLower TargetBuy ➝ Buy$60.00 ➝ $55.00
4/23/2025Truist FinancialLower TargetBuy ➝ Buy$60.00 ➝ $50.00
4/22/2025BarclaysLower TargetOverweight ➝ Overweight$60.00 ➝ $50.00
4/22/2025Stifel NicolausLower TargetBuy ➝ Buy$57.00 ➝ $53.00
4/22/2025BTIG ResearchLower TargetBuy ➝ Buy$64.00 ➝ $52.00
4/14/2025Cfra ResearchUpgradeModerate Buy
4/13/2025Jefferies Financial GroupSet TargetBuy ➝ Buy$60.00
4/10/2025GuggenheimLower TargetBuy ➝ Buy$62.00 ➝ $61.00
4/7/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$65.00 ➝ $65.00
4/2/2025CitigroupReiterated RatingOutperform ➝ Outperform
4/2/2025JMP SecuritiesSet Target$57.00
3/10/2025BenchmarkBoost TargetBuy ➝ Buy$44.00 ➝ $51.00
2/24/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$49.00 ➝ $53.00
2/18/2025Needham & Company LLCSet Target$65.00
2/18/2025ArgusSet Target$60.00
2/18/2025JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$53.00 ➝ $61.00
2/18/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$48.00 ➝ $60.00
2/18/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$53.00 ➝ $60.00
2/18/2025BarclaysBoost TargetOverweight ➝ Overweight$50.00 ➝ $60.00
2/18/2025Truist FinancialBoost TargetBuy ➝ Buy$50.00 ➝ $60.00
2/18/2025Stifel NicolausBoost TargetBuy ➝ Buy$48.00 ➝ $57.00
2/14/2025BenchmarkBoost TargetBuy ➝ Buy$44.00 ➝ $51.00
2/14/2025JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$50.00 ➝ $50.00
2/14/2025Canaccord Genuity GroupBoost TargetBuy ➝ Buy$54.00 ➝ $60.00
2/14/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
2/7/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
2/4/2025CowenReiterated RatingBuy ➝ Buy
2/4/2025TD CowenLower TargetBuy ➝ Buy$55.00 ➝ $51.00
2/3/2025BTIG ResearchSet Target$59.00
1/8/2025SusquehannaLower TargetPositive ➝ Positive$56.00 ➝ $54.00
1/7/2025BenchmarkReiterated RatingBuy ➝ Buy$44.00 ➝ $44.00
1/6/2025JMP SecuritiesLower TargetMarket Outperform ➝ Market Outperform$52.00 ➝ $50.00
12/13/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$47.00 ➝ $53.00
11/12/2024TD CowenBoost TargetBuy ➝ Buy$50.00 ➝ $55.00
11/11/2024MacquarieBoost TargetOutperform ➝ Outperform$50.00 ➝ $51.00
11/11/2024BarclaysBoost TargetOverweight ➝ Overweight$45.00 ➝ $50.00
11/11/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$51.00 ➝ $52.00
11/8/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
10/22/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$47.00 ➝ $48.00
10/18/2024MizuhoBoost TargetOutperform ➝ Outperform$54.00 ➝ $62.00
10/17/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$47.00 ➝ $52.00
10/16/2024BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$48.00 ➝ $48.00
10/14/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$51.00 ➝ $51.00
10/7/2024BenchmarkReiterated RatingBuy ➝ Buy$44.00 ➝ $44.00
10/7/2024SusquehannaBoost TargetPositive ➝ Positive$48.00 ➝ $50.00
10/4/2024BarclaysBoost TargetOverweight ➝ Overweight$43.00 ➝ $45.00
9/26/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$48.00 ➝ $54.00
9/23/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
9/16/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
9/11/2024Morgan StanleyReiterated RatingOverweight ➝ Overweight$47.00 ➝ $47.00
9/10/2024BNP ParibasUpgradeUnderperform ➝ Neutral$35.00
9/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
9/4/2024UBS GroupBoost TargetBuy ➝ Buy$56.00 ➝ $58.00
9/4/2024SusquehannaBoost TargetPositive ➝ Positive$47.00 ➝ $48.00
9/3/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
8/26/2024MacquarieReiterated RatingOutperform ➝ Outperform$50.00 ➝ $50.00
8/20/2024BenchmarkBoost TargetBuy ➝ Buy$41.00 ➝ $44.00
8/14/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
8/14/2024Truist FinancialReiterated RatingBuy ➝ Buy$50.00 ➝ $50.00
8/13/2024Morgan StanleyLower TargetOverweight ➝ Overweight$51.00 ➝ $47.00
8/5/2024BarclaysLower TargetOverweight ➝ Overweight$53.00 ➝ $43.00
8/5/2024OppenheimerLower TargetOutperform ➝ Outperform$58.00 ➝ $55.00
8/5/2024MacquarieLower TargetOutperform ➝ Outperform$52.00 ➝ $50.00
8/5/2024Truist FinancialLower TargetBuy ➝ Buy$53.00 ➝ $50.00
8/5/2024Stifel NicolausReiterated RatingBuy ➝ Buy$50.00 ➝ $48.00
8/5/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$53.00 ➝ $47.00
8/5/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
8/5/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$60.00 ➝ $54.00
8/2/2024BenchmarkLower TargetBuy ➝ Buy$52.00 ➝ $41.00
8/2/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$54.00 ➝ $48.00
8/1/2024SusquehannaLower TargetPositive ➝ Positive$49.00 ➝ $47.00
7/24/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
7/22/2024Bank of AmericaLower TargetBuy ➝ Buy$54.00 ➝ $50.00
7/18/2024MacquarieLower TargetOutperform ➝ Outperform$54.00 ➝ $52.00
7/18/2024Truist FinancialLower TargetBuy ➝ Buy$55.00 ➝ $53.00
7/10/2024BarclaysLower TargetOverweight ➝ Overweight$54.00 ➝ $53.00
7/5/2024Stifel NicolausReiterated RatingBuy ➝ Buy$50.00 ➝ $50.00
7/1/2024OppenheimerLower TargetOutperform ➝ Outperform$60.00 ➝ $58.00
6/26/2024GuggenheimLower TargetBuy ➝ Buy$53.00 ➝ $52.00
6/25/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$54.00 ➝ $53.00
6/12/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
6/5/2024SusquehannaLower TargetPositive ➝ Positive$56.00 ➝ $49.00
5/31/2024Berenberg BankUpgradeHold
5/29/2024Stifel NicolausLower TargetBuy ➝ Buy$51.00 ➝ $50.00
5/28/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
5/28/2024OppenheimerReiterated RatingOutperform ➝ Outperform$60.00 ➝ $60.00
5/15/2024UBS GroupBoost TargetBuy ➝ Buy$56.00 ➝ $60.00
5/6/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$52.00 ➝ $54.00
5/6/2024Stifel NicolausBoost TargetBuy ➝ Buy$50.00 ➝ $51.00
5/6/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$34.00 ➝ $35.00
5/6/2024BarclaysBoost TargetOverweight ➝ Overweight$52.00 ➝ $54.00
5/6/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$51.00 ➝ $54.00
5/6/2024BTIG ResearchBoost TargetBuy ➝ Buy$53.00 ➝ $55.00
5/3/2024BenchmarkBoost TargetBuy ➝ Buy$50.00 ➝ $52.00
5/3/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$58.00 ➝ $58.00
4/29/2024SusquehannaBoost TargetPositive ➝ Positive$54.00 ➝ $56.00
4/24/2024BenchmarkReiterated RatingBuy ➝ Buy$50.00
4/19/2024BarclaysBoost TargetOverweight ➝ Overweight$50.00 ➝ $52.00
4/16/2024The Goldman Sachs GroupInitiated CoverageBuy$60.00
4/9/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$49.00 ➝ $50.00
3/28/2024JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Overweight$55.00
3/28/2024Moffett NathansonBoost TargetBuy ➝ Buy$52.00 ➝ $55.00
3/27/2024Needham & Company LLCBoost TargetBuy ➝ Buy$54.00 ➝ $58.00
3/26/2024MizuhoInitiated CoverageBuy$58.00
3/25/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$52.00
3/25/2024SusquehannaBoost TargetPositive ➝ Positive$51.00 ➝ $54.00
3/5/2024UBS GroupBoost TargetBuy ➝ Buy$44.00 ➝ $56.00
2/28/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$40.00 ➝ $49.00
2/23/2024BarclaysUpgradeEqual Weight ➝ Overweight$41.00 ➝ $50.00
2/20/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$39.00 ➝ $53.00
2/20/2024Truist FinancialReiterated RatingBuy ➝ Buy$45.00 ➝ $55.00
2/20/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$36.00 ➝ $41.00
2/20/2024OppenheimerBoost TargetOutperform ➝ Outperform$55.00 ➝ $60.00
2/16/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$43.00 ➝ $51.00
2/16/2024SusquehannaBoost TargetPositive ➝ Positive$49.00 ➝ $51.00
2/16/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$50.00 ➝ $54.00
2/15/2024Bank Of America (Bofa)Boost Target$45.00 ➝ $50.00
2/13/2024OppenheimerBoost TargetOutperform ➝ Outperform$44.00 ➝ $55.00
2/13/2024Piper SandlerBoost TargetOverweight ➝ Overweight$40.00 ➝ $50.00
1/19/2024BNP ParibasDowngradeNeutral ➝ Underperform$28.00
1/19/2024Stifel NicolausUpgradeHold ➝ Buy$40.00 ➝ $45.00
1/9/2024BMO Capital MarketsInitiated CoverageOutperform$43.00
12/26/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$50.00
11/27/2023ArgusBoost TargetBuy ➝ Buy$40.00 ➝ $46.00
11/27/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$50.00
11/20/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$50.00
11/15/2023Craig HallumBoost TargetBuy ➝ Buy$40.00 ➝ $45.00
11/15/2023GuggenheimBoost TargetBuy ➝ Buy$39.00 ➝ $45.00
11/15/2023BenchmarkBoost TargetBuy ➝ Buy$37.00 ➝ $41.00
11/13/2023SusquehannaBoost TargetPositive ➝ Positive$37.00 ➝ $42.00
11/13/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$50.00
11/7/2023UBS GroupBoost TargetBuy ➝ Buy$39.00 ➝ $44.00
11/6/2023Truist FinancialBoost TargetBuy ➝ Buy$44.00 ➝ $45.00
11/6/2023Needham & Company LLCBoost TargetBuy ➝ Buy$44.00 ➝ $50.00
11/3/2023SusquehannaLower TargetPositive ➝ Positive$40.00 ➝ $37.00
10/24/2023Moffett NathansonUpgradeHold ➝ Buy$37.00
10/16/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$44.00
10/13/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$35.00 ➝ $36.00
10/4/2023GuggenheimLower TargetBuy ➝ Buy$38.00 ➝ $37.00
10/2/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$44.00
9/26/2023BenchmarkReiterated RatingBuy ➝ Buy$37.00
9/26/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$26.00 ➝ $37.00
9/25/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$39.00
9/25/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$44.00
9/18/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$44.00
9/15/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$39.00
9/11/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$44.00
9/7/2023BarclaysBoost Target$30.00 ➝ $32.00
9/5/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$39.00
8/21/2023UBS GroupBoost Target$30.00 ➝ $39.00
8/10/2023ArgusBoost TargetBuy ➝ Buy$30.00 ➝ $34.00
8/9/2023CitigroupBoost TargetBuy ➝ Buy$30.00 ➝ $41.00
8/9/2023JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$26.00
8/8/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$32.00 ➝ $35.00
8/8/2023Truist FinancialUpgradeHold ➝ Buy$31.00 ➝ $44.00
8/7/2023Roth MkmBoost TargetSell ➝ Sell$20.00 ➝ $23.00
8/7/2023TD CowenBoost TargetOutperform ➝ Outperform$35.00 ➝ $37.00
8/7/2023Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$24.00 ➝ $27.00
8/7/2023BarclaysBoost TargetEqual Weight ➝ Equal Weight$29.00 ➝ $30.00
8/7/2023OppenheimerBoost TargetOutperform ➝ Outperform$36.00 ➝ $40.00
8/7/2023SusquehannaBoost Target$39.00 ➝ $40.00
8/7/2023JMP SecuritiesBoost TargetOutperform ➝ Outperform$33.00 ➝ $39.00
8/7/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$28.00 ➝ $37.00
8/6/2023Jefferies Financial GroupBoost TargetBuy ➝ Buy$38.00 ➝ $42.00
8/4/2023Craig HallumBoost TargetBuy ➝ Buy$35.00 ➝ $40.00
8/4/2023BTIG ResearchBoost Target$34.00 ➝ $39.00
8/4/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$36.00
8/4/2023BenchmarkBoost TargetBuy ➝ Buy$32.00 ➝ $37.00
8/3/2023Stifel NicolausBoost Target$25.00 ➝ $32.00
7/25/2023TD CowenBoost TargetOutperform$30.00 ➝ $35.00
7/21/2023BarclaysBoost TargetEqual Weight$24.00 ➝ $29.00
7/18/2023Roth MkmBoost TargetSell$18.00 ➝ $20.00
7/18/2023Truist FinancialBoost TargetHold$26.00 ➝ $31.00
7/17/2023Jefferies Financial GroupBoost TargetBuy$35.00 ➝ $38.00
7/14/2023Piper SandlerBoost Target$30.00 ➝ $35.00
7/14/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$31.00 ➝ $32.00
7/13/2023BTIG ResearchBoost TargetBuy$31.00 ➝ $34.00
7/13/2023JMP SecuritiesBoost Target$31.00 ➝ $33.00
7/12/2023BenchmarkBoost TargetBuy$26.00 ➝ $32.00
7/12/2023Bank of AmericaUpgradeNeutral ➝ Buy$25.00 ➝ $35.00
7/7/2023OppenheimerBoost Target$30.00 ➝ $36.00
7/6/2023Deutsche Bank AktiengesellschaftBoost Target$22.00 ➝ $24.00
6/29/2023SusquehannaBoost Target$36.00 ➝ $39.00
6/27/2023VNET GroupReiterated RatingReiterates
6/23/2023Wells Fargo & CompanyBoost Target$24.00 ➝ $28.00
6/5/2023BTIG ResearchBoost Target$27.00 ➝ $31.00
6/5/2023JMP SecuritiesBoost Target$29.00 ➝ $31.00
6/5/2023Jefferies Financial GroupBoost Target$33.00 ➝ $35.00
5/22/2023UBS GroupUpgradeNeutral ➝ Buy$19.00 ➝ $30.00
5/14/2023CitigroupBoost Target$25.00 ➝ $30.00
5/8/2023GuggenheimBoost Target$27.00 ➝ $32.00
5/8/2023Roth MkmBoost TargetSell$15.00 ➝ $18.00
5/8/2023Truist FinancialBoost Target$23.00 ➝ $26.00
5/8/2023SusquehannaBoost Target$28.00 ➝ $36.00
5/8/2023JMP SecuritiesBoost Target$26.00 ➝ $29.00
5/8/2023BarclaysBoost Target$23.00 ➝ $24.00
5/8/2023Deutsche Bank AktiengesellschaftBoost Target$15.00 ➝ $22.00
5/5/2023BenchmarkBoost TargetBuy$23.00 ➝ $26.00
5/5/2023OppenheimerBoost TargetOutperform$28.00 ➝ $30.00
5/5/2023Bank of AmericaBoost TargetNeutral$24.00 ➝ $25.00
5/5/2023BTIG ResearchBoost TargetBuy$25.00 ➝ $27.00
5/4/2023Stifel NicolausBoost Target$21.00 ➝ $23.00
4/13/2023JMP SecuritiesReiterated RatingMarket Outperform$26.00
4/13/2023BNP ParibasUpgradeUnderperform ➝ Neutral$17.00
3/22/2023SusquehannaBoost TargetPositive$26.00 ➝ $28.00
3/21/2023BenchmarkReiterated RatingBuy$23.00
3/13/2023BTIG ResearchBoost TargetBuy$24.00 ➝ $25.00
3/7/2023ArgusUpgradeHold ➝ Buy$22.00
2/22/2023Morgan StanleyBoost TargetOverweight$20.00 ➝ $22.00
2/21/2023Canaccord Genuity GroupBoost TargetBuy$28.00 ➝ $30.00
2/21/2023Truist FinancialBoost TargetHold$15.00 ➝ $23.00
2/21/2023JMP SecuritiesBoost TargetMarket Outperform$23.00 ➝ $26.00
2/21/2023Needham & Company LLCBoost Target$20.00 ➝ $28.00
2/21/2023OppenheimerBoost TargetOutperform$23.00 ➝ $28.00
2/20/2023Wells Fargo & CompanyBoost Target$16.00 ➝ $22.00
2/17/2023Needham & Company LLCReiterated RatingBuy$20.00
2/17/2023Craig HallumBoost TargetBuy$21.00 ➝ $27.00
2/17/2023BTIG ResearchUpgradeNeutral ➝ Buy$24.00
2/15/2023Stifel NicolausBoost TargetHold$15.00 ➝ $17.00
2/15/2023SusquehannaBoost TargetPositive$19.00 ➝ $24.00
2/9/2023Roth MkmDowngradeNeutral ➝ Sell$15.00
2/9/2023Roth CapitalDowngradeNeutral ➝ Sell$15.00
2/9/2023MKM PartnersDowngradeNeutral ➝ Sell$15.00
1/23/2023Stifel NicolausInitiated CoverageHold$15.00
1/6/2023Piper SandlerLower TargetOverweight$21.00 ➝ $15.00
12/12/2022Roth CapitalDowngradeBuy ➝ Neutral$15.00
11/28/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$12.00
11/21/2022Morgan StanleyLower TargetOverweight$28.00 ➝ $20.00
11/18/2022Piper SandlerInitiated CoverageOverweight$21.00
11/7/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$32.00 ➝ $28.00
11/7/2022Morgan StanleyLower TargetOverweight$30.00 ➝ $28.00
11/7/2022Needham & Company LLCLower TargetBuy$25.00 ➝ $20.00
11/7/2022Craig HallumLower TargetBuy$30.00 ➝ $21.00
11/7/2022GuggenheimLower TargetBuy$31.00 ➝ $27.00
11/7/2022Deutsche Bank AktiengesellschaftLower TargetHold$16.00 ➝ $14.00
11/7/2022BarclaysLower TargetEqual Weight$18.00 ➝ $15.00
11/2/2022CowenLower Target$50.00 ➝ $35.00
11/2/2022CowenLower TargetOutperform$50.00 ➝ $35.00
10/25/2022Truist FinancialLower TargetHold$20.00 ➝ $15.00
10/12/2022Redburn PartnersInitiated CoverageNeutral$19.00
10/12/2022BenchmarkLower TargetBuy$30.00 ➝ $23.00
10/6/2022Exane BNP ParibasInitiated CoverageUnderperform
10/6/2022BNP ParibasInitiated CoverageUnderperform
9/14/2022GuggenheimLower Target$31.00
9/6/2022Susquehanna BancsharesBoost TargetPositive$20.00 ➝ $24.00
9/6/2022SusquehannaBoost TargetPositive$20.00 ➝ $24.00
8/17/2022Roth CapitalUpgradeNeutral ➝ Buy$18.00 ➝ $25.00
8/15/2022GuggenheimLower Target$34.00
8/15/2022BenchmarkBoost Target$30.00
8/9/2022BenchmarkBoost Target$30.00
8/8/2022Morgan StanleyLower TargetOverweight ➝ Overweight$31.00 ➝ $30.00
8/8/2022Truist FinancialBoost TargetHold$16.00 ➝ $20.00
8/8/2022BarclaysBoost TargetEqual Weight$14.00 ➝ $18.00
7/20/2022Truist FinancialLower TargetHold$18.00 ➝ $16.00
7/7/2022CitigroupLower TargetBuy$26.00 ➝ $20.00
6/28/2022BarclaysInitiated CoverageEqual Weight$14.00
6/28/2022JMP SecuritiesInitiated CoverageOutperform$25.00
6/23/2022Morgan StanleyReiterated RatingOverweight$31.00
5/31/2022CitigroupLower TargetBuy$35.00 ➝ $28.00
5/16/2022Jefferies Financial GroupInitiated CoverageBuy ➝ Buy
5/9/2022Northland SecuritiesLower Target$40.00 ➝ $25.00
5/9/2022Craig HallumLower Target$40.00 ➝ $30.00
5/9/2022Canaccord Genuity GroupLower Target$40.00 ➝ $34.00
5/9/2022OppenheimerLower Target$32.00 ➝ $24.00
5/9/2022Needham & Company LLCLower Target$32.00 ➝ $25.00
5/9/2022Deutsche Bank AktiengesellschaftLower Target$19.00 ➝ $16.00
5/9/2022Loop CapitalLower Target$35.00 ➝ $25.00
5/4/2022CowenLower Target$60.00 ➝ $50.00
3/17/2022UBS GroupLower TargetNeutral$44.00 ➝ $18.00
3/7/2022ArgusDowngradeBuy ➝ Hold
3/4/2022UBS GroupReiterated RatingHold$44.00
2/23/2022CitigroupLower TargetBuy$40.00 ➝ $35.00
2/22/2022OppenheimerLower TargetOutperform$35.00 ➝ $32.00
2/22/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$65.00 ➝ $55.00
2/22/2022Craig HallumLower Target$51.00 ➝ $40.00
2/22/2022Roth CapitalUpgradeSell ➝ Neutral$23.00 ➝ $19.00
2/22/2022Northland SecuritiesLower Target$45.00 ➝ $40.00
2/22/2022Truist FinancialLower TargetHold$30.00 ➝ $22.00
2/22/2022Bank of AmericaLower TargetNeutral$30.00 ➝ $25.00
2/22/2022Deutsche Bank AktiengesellschaftLower TargetHold$27.00 ➝ $19.00
2/22/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$41.00 ➝ $19.00
2/22/2022Needham & Company LLCLower TargetBuy$46.00 ➝ $32.00
2/21/2022Morgan StanleyUpgradeBuy$31.00
2/17/2022CowenLower Target$70.00 ➝ $60.00
2/14/2022OppenheimerLower Target$70.00 ➝ $35.00
1/26/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$31.00
1/21/2022Needham & Company LLCLower Target$73.00 ➝ $46.00
1/21/2022Northland SecuritiesLower Target$75.00 ➝ $45.00
1/18/2022Morgan StanleyLower TargetEqual Weight$53.00 ➝ $31.00
1/13/2022Truist FinancialLower Target$50.00 ➝ $30.00
1/12/2022Roth CapitalReiterated RatingSell$23.00
1/11/2022Deutsche Bank AktiengesellschaftLower Target$46.00 ➝ $27.00
1/4/2022Craig HallumLower Target$70.00 ➝ $51.00
12/23/2021Wells Fargo & CompanyReiterated RatingBuy$41.00
12/17/2021Wells Fargo & CompanyLower TargetOverweight$58.00 ➝ $41.00
12/13/2021Moffett NathansonInitiated CoverageNeutral$36.00
12/7/2021CBRE GroupInitiated CoverageHold$36.00
12/7/2021CitigroupInitiated CoverageHold$36.00
11/15/2021Roth CapitalLower TargetNeutral ➝ Sell$39.00 ➝ $34.00
11/11/2021CitigroupLower TargetBuy$66.00 ➝ $58.00
11/9/2021BTIG ResearchReiterated RatingHold
11/8/2021Roth CapitalLower TargetSell$41.00 ➝ $39.00
11/8/2021Deutsche Bank AktiengesellschaftLower TargetHold$51.00 ➝ $46.00
11/8/2021Truist FinancialLower TargetHold$55.00 ➝ $50.00
11/8/2021OppenheimerLower TargetOutperform$80.00 ➝ $70.00
11/2/2021Morgan StanleyInitiated CoverageEqual Weight$53.00
10/27/2021BTIG ResearchInitiated CoverageNeutral
10/12/2021Roth CapitalInitiated CoverageSell$41.00
10/11/2021CitigroupInitiated CoverageBuy$66.00
9/15/2021Credit Suisse GroupReiterated RatingBuy$85.00
9/14/2021Wells Fargo & CompanyInitiated CoverageOverweight$73.00
9/14/2021Craig HallumBoost TargetBuy$60.00 ➝ $70.00
8/9/2021Needham & Company LLCInitiated CoverageBuy$73.00
8/9/2021Northland SecuritiesBoost TargetOutperform$70.00 ➝ $75.00
8/9/2021BenchmarkBoost TargetBuy$64.00 ➝ $70.00
7/29/2021Morgan StanleyBoost TargetOverweight$58.00 ➝ $60.00
7/28/2021The Goldman Sachs GroupLower TargetBuy$77.00 ➝ $73.00
7/7/2021OppenheimerInitiated CoverageBuy$80.00
6/2/2021Morgan StanleyLower TargetOverweight$63.00 ➝ $58.00
5/24/2021ArgusLower TargetBuy$78.00 ➝ $60.00
5/12/2021Berenberg BankUpgradeSell ➝ Hold$41.00 ➝ $42.50
5/10/2021Craig HallumLower TargetBuy$70.00 ➝ $60.00
5/10/2021Morgan StanleyLower TargetOverweight$66.00 ➝ $63.00
5/10/2021Needham & Company LLCLower TargetBuy$81.00 ➝ $73.00
5/7/2021Cannonball ResearchReiterated RatingBuy$80.00
5/3/2021CowenUpgradeMarket Perform ➝ Outperform$70.00
4/30/2021OppenheimerInitiated CoverageBuy$75.00
4/30/2021GuggenheimInitiated CoverageBuy$75.00
4/26/2021Needham & Company LLCInitiated CoverageBuy$81.00
3/23/2021The Goldman Sachs GroupBoost TargetBuy$79.00 ➝ $87.00
3/16/2021Jefferies Financial GroupReiterated RatingBuy$73.00 ➝ $75.00
3/10/2021Jefferies Financial GroupBoost TargetBuy$73.00 ➝ $75.00
3/10/2021BenchmarkBoost TargetBuy$69.00 ➝ $75.00
3/10/2021Credit Suisse GroupBoost TargetOutperform$84.00 ➝ $85.00
3/10/2021MacquarieBoost TargetOutperform$71.00 ➝ $73.00
3/8/2021Rosenblatt SecuritiesBoost TargetBuy$72.00 ➝ $81.00
3/1/2021Piper SandlerBoost Target$58.00 ➝ $67.00
3/1/2021Craig HallumBoost TargetPositive ➝ Buy$65.00 ➝ $70.00
3/1/2021Morgan StanleyBoost TargetOverweight$60.00 ➝ $66.00
3/1/2021Northland SecuritiesBoost TargetOutperform$55.00 ➝ $70.00
3/1/2021Rosenblatt SecuritiesBoost TargetBuy$65.00 ➝ $72.00
3/1/2021Needham & Company LLCReiterated RatingBuy$80.00
3/1/2021BenchmarkBoost TargetBuy$66.00 ➝ $69.00
3/1/2021UBS GroupBoost TargetNeutral$52.00 ➝ $65.00
3/1/2021The Goldman Sachs GroupBoost TargetBuy$71.00 ➝ $73.00
2/19/2021OppenheimerBoost Target$65.00 ➝ $80.00
2/1/2021BenchmarkBoost TargetBuy$60.00 ➝ $66.00
1/26/2021Sanford C. BernsteinInitiated CoverageOutperform$71.00
1/26/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$45.00 ➝ $65.00
1/20/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$39.00 ➝ $60.00
1/19/2021Berenberg BankInitiated CoverageSell$41.00
1/14/2021Truist FinancialBoost Target$48.00 ➝ $60.00
12/18/2020Bank of AmericaBoost Target$55.00 ➝ $60.00
12/7/2020JPMorgan Chase & Co.Initiated CoverageNeutral$48.00 ➝ $48.00
11/24/2020UBS GroupInitiated CoverageNeutral$52.00
11/19/2020Piper SandlerInitiated CoverageOverweight$58.00
11/16/2020Loop CapitalInitiated CoverageBuy$100.00
11/16/2020Northland SecuritiesBoost TargetOutperform$50.00 ➝ $55.00
11/16/2020Deutsche Bank AktiengesellschaftLower TargetHold$48.00 ➝ $46.00
11/16/2020Morgan StanleyBoost TargetEqual Weight$37.00 ➝ $39.00
11/4/2020OppenheimerReiterated RatingBuy$65.00
10/13/2020Rosenblatt SecuritiesBoost TargetBuy$60.00 ➝ $65.00
10/12/2020BenchmarkBoost TargetBuy$57.00 ➝ $60.00
10/12/2020OppenheimerBoost TargetOutperform$55.00 ➝ $65.00
10/12/2020Credit Suisse GroupInitiated CoverageOutperform$76.00
10/12/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$48.00
10/8/2020Truist FinancialBoost Target$39.00 ➝ $60.00
10/8/2020CowenInitiated CoverageMarket Perform$55.00
9/30/2020Needham & Company LLCInitiated CoverageBuy$70.00
9/25/2020ArgusInitiated CoverageBuy$65.00
9/24/2020MacquarieInitiated CoverageOutperform$65.00 ➝ $65.00
9/15/2020Craig HallumBoost Target$48.00 ➝ $60.00
9/15/2020OppenheimerBoost Target$50.00 ➝ $55.00
9/15/2020BenchmarkBoost TargetBuy$45.00 ➝ $57.00
9/14/2020Wolfe ResearchInitiated CoveragePeer Perform
9/9/2020Evercore ISIInitiated CoverageOutperform$60.00
9/8/2020Bank of AmericaInitiated CoverageNeutral$40.00
9/2/2020Truist FinancialInitiated CoverageHold$39.00 ➝ $39.00
8/28/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$37.00
8/26/2020OppenheimerReiterated RatingBuy$50.00
8/24/2020Rosenblatt SecuritiesReiterated RatingBuy$60.00
8/19/2020Northland SecuritiesReiterated RatingBuy$50.00
8/17/2020Jefferies Financial GroupReiterated RatingBuy$55.00
8/17/2020BenchmarkLower TargetBuy$47.00 ➝ $45.00
8/16/2020Rosenblatt SecuritiesReiterated RatingBuy$60.00
8/14/2020Morgan StanleyBoost TargetOverweight$25.00 ➝ $26.00
7/31/2020BenchmarkInitiated CoverageBuy$47.00
7/26/2020OppenheimerInitiated CoverageBuy$46.00
7/1/2020OppenheimerInitiated CoverageBuy$46.00
6/30/2020StephensInitiated CoverageOverweight$52.00
6/25/2020Rosenblatt SecuritiesInitiated CoverageBuy$60.00
6/24/2020The Goldman Sachs GroupBoost TargetNeutral$32.00 ➝ $34.00
6/23/2020OppenheimerReiterated RatingBuy$48.00
6/22/2020Jefferies Financial GroupInitiated CoverageBuy$55.00 ➝ $55.00
6/12/2020Craig HallumReiterated RatingBuy
6/10/2020OppenheimerInitiated CoverageOutperform$48.00 ➝ $48.00
6/7/2020Northland SecuritiesReiterated RatingBuy
6/5/2020Northland SecuritiesBoost TargetOutperform ➝ Positive$33.00 ➝ $50.00
6/3/2020Susquehanna BancsharesBoost Target$35.00 ➝ $48.00
5/26/2020Cannonball ResearchInitiated CoverageBuy$35.00
5/19/2020The Goldman Sachs GroupInitiated CoverageNeutral$32.00
5/18/2020Morgan StanleyBoost TargetOverweight$23.00 ➝ $25.00
5/18/2020Northland SecuritiesReiterated RatingAverage ➝ Outperform$24.00 ➝ $33.00
5/14/2020Craig HallumBoost TargetBuy$25.00 ➝ $30.00
5/14/2020Susquehanna BancsharesInitiated CoveragePositive$33.00
5/11/2020Northland SecuritiesReiterated RatingBuy$24.00
5/4/2020Northland SecuritiesInitiated CoverageOutperform$24.00
4/30/2020Morgan StanleyInitiated CoverageOverweight$23.00
(Data available from 4/25/2020 forward)

News Sentiment Rating

1.03 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 45 very positive mentions
  • 35 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2024
  • 27 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 47 very positive mentions
  • 41 positive mentions
  • 6 negative mentions
  • 2 very negative mentions
Mentions as of
11/26/2024
  • 49 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2024
  • 27 very positive mentions
  • 17 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2025
  • 71 very positive mentions
  • 38 positive mentions
  • 12 negative mentions
  • 3 very negative mentions
Mentions as of
2/24/2025
  • 67 very positive mentions
  • 23 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
3/26/2025
  • 60 very positive mentions
  • 24 positive mentions
  • 10 negative mentions
  • 2 very negative mentions
Mentions as of
4/25/2025

Current Sentiment

  • 60 very positive mentions
  • 24 positive mentions
  • 10 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

DraftKings logo
DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally. It provides online sports betting and casino, daily fantasy sports, media, and other consumer products, as well as retails sportsbooks. The company also engages in the design and development of sports betting and casino gaming software for online and retail sportsbooks, and iGaming operators. In addition, it offers DraftKings marketplace, a digital collectibles ecosystem designed for mainstream accessibility that offers curated NFT drops and supports secondary-market transactions. The company is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $33.79
Low: $33.26
High: $34.09

50 Day Range

MA: $37.56
Low: $31.67
High: $50.78

52 Week Range

Now: $33.79
Low: $28.69
High: $53.61

Volume

10,415,595 shs

Average Volume

9,795,437 shs

Market Capitalization

$29.84 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.16

Frequently Asked Questions

What sell-side analysts currently cover shares of DraftKings?

The following Wall Street research analysts have issued stock ratings on DraftKings in the last twelve months: Argus, Bank of America Co., Barclays PLC, Benchmark Co., Berenberg Bank, BMO Capital Markets, BNP Paribas, BTIG Research, Canaccord Genuity Group Inc., Cfra Research, Citigroup Inc., Cowen Inc, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., JMP Securities, JPMorgan Chase & Co., Macquarie, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Stifel Nicolaus, Susquehanna, TD Cowen, TD Securities, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for DKNG.

What is the current price target for DraftKings?

0 Wall Street analysts have set twelve-month price targets for DraftKings in the last year. Their average twelve-month price target is $54.74, suggesting a possible upside of 62.1%. BMO Capital Markets has the highest price target set, predicting DKNG will reach $65.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $35.00 for DraftKings in the next year.
View the latest price targets for DKNG.

What is the current consensus analyst rating for DraftKings?

DraftKings currently has 3 hold ratings and 26 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for DKNG.

What other companies compete with DraftKings?

Other companies that are similar to DraftKings include TKO Group, Endeavor Group, Warner Music Group, Planet Fitness and Life Time Group. Learn More about companies similar to DraftKings.

How do I contact DraftKings' investor relations team?

DraftKings' physical mailing address is 2121 AVENUE OF THE STARS SUITE 2300, LOS ANGELES CA, 90067. The company's listed phone number is 617-986-6744 and its investor relations email address is [email protected]. The official website for DraftKings is www.draftkings.com. Learn More about contacing DraftKings investor relations.